LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

The Development of a Virtual Liquid Chromatography Method Development Tool

Posters | 2023 | Restek | HPLC SymposiumInstrumentation
HPLC
Industries
Other
Manufacturer
Restek

Summary

Significance of the Topic


The optimization and validation of liquid chromatography (LC) methods are fundamental to modern analytical laboratories, especially in fields such as forensic toxicology, pharmaceuticals, environmental monitoring and quality control.

Instrument downtime, resource constraints and lengthy trial-and-error approaches hinder rapid method deployment and can increase costs.

Virtual modeling tools that predict retention behavior and optimize separation conditions without tying up analytical hardware offer a means to accelerate method development and improve reproducibility across laboratories.

Objectives and Study Overview


This work describes the creation and evaluation of a free, instrument-independent LC method development tool designed around a comprehensive Drugs of Abuse (DoA) library.

The main goals were to:

  • Implement a software modeler capable of simulating retention times under diverse chromatographic conditions.
  • Validate the model across different stationary phases, column dimensions, organic modifiers, gradient profiles and temperatures.
  • Demonstrate transferability and accuracy by comparing modeled retention to empirical data on multiple instrument platforms.

Methodology and Instrumentation


A three-stage verification protocol was adopted to systematically introduce potential error sources and refine model parameters.

Stage 1: New column dimension evaluation using 30 analytes on Raptor Biphenyl 2.7 µm, 50 × 2.1 mm.

Stage 2: Assessment of flow rates, temperatures and gradient slopes at 30 °C, 45 °C and 60 °C with ACN and MeOH mobile phases (0.1% formic acid).

Stage 3: Full user simulation with both Raptor Biphenyl and Raptor C18 stationary phases, multiple column lengths (30, 50, 100 × 2.1 mm), multistep gradients and isocratic holds.

Used Instrumentation
  • Columns: Raptor Biphenyl and Raptor C18, 2.7 µm particles, dimensions 30–150 × 2.1–3.0 mm.
  • Mobile phases: A – water + 0.1% formic acid; B – methanol + 0.1% formic acid.
  • Flow rate: 0.8 mL/min; column temperature range 30–60 °C.
  • Detection: Triple quadrupole MS/MS with ESI positive mode, MRM transitions.

Key Results and Discussion


Validation against empirical data for 50 initial compounds and an expanded set of 180 DoA analytes yielded:

  • Overall pass rate of 98.15% for modeled retention within ±15 s of experimental values.
  • Median percentage differences below 3.6% across all tested variables.
  • Robust performance across two stationary phases, three gradient types (linear, isocratic hold, multistep), three temperatures and multiple column lengths.

Only 13 out of 704 data points exceeded the ±15 s window, demonstrating high predictive reliability.

Benefits and Practical Applications


The virtual LC method tool enables:

  • Significant reduction in instrument-occupied time during method development.
  • Rapid exploration of chromatographic variables without physical screening.
  • Improved consistency and transferability of methods between labs and instrument platforms.
  • Lower costs and faster turnaround, especially for laboratories with limited LC-MS resources.

Future Trends and Opportunities


Upcoming enhancements planned for 2023 and beyond include:

  • Addition of fully porous particle (FPP) columns and superficial porous particles (SPP) in various sizes.
  • Expanded psychoactive substance (NPS) and cannabinoid libraries.
  • Inclusion of UV detection modules and multilingual user interfaces.
  • Support for additional mobile phase chemistries and alternative ionization modes.

Conclusion


The presented virtual LC method development tool demonstrates high accuracy in predicting retention behavior across a wide range of chromatographic conditions.

By freeing up instrument time and accelerating method design, it supports both novice and expert users in achieving efficient, reproducible separations.

This approach represents a significant step toward more sustainable and cost-effective LC method development.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
The Development of a Virtual Liquid Chromatography Method Development Tool
The Development of a Virtual Liquid Chromatography Method Development Tool Melinda Uricha, Jamie Yorka, John Garrettb, Chris Nelsona, Tim Yoscaa, Justin Steimlinga a Restek, Bellefonte, PA b Analytical Innovations Inc., Dayton, OH Introduction and Background Laboratories implementing new methods or…
Key words
phenazepam, phenazepamtime, timemodeler, modelermethylephedrine, methylephedrinemethaqualone, methaqualonenorketamine, norketaminelevetiracetam, levetiracetammin, minphentermine, phenterminetool, tooldiphenhydramine, diphenhydramineempirical, empiricaldiff, diffmethamphetamine, methamphetaminevirtual
The Development of a Virtual Liquid Chromatography Method Development Tool
The Development of a Virtual Liquid Chromatography Method Development Tool Melinda Uricha, Jamie Yorka, John Garrettb, Chris Nelsona, Tim Yoscaa, Justin Steimlinga a Restek, Bellefonte, PA b Analytical Innovations Inc., Dayton, OH Introduction and Background Laboratories implementing new methods or…
Key words
phenazepam, phenazepamtime, timemodeler, modelermethylephedrine, methylephedrinemethaqualone, methaqualonenorketamine, norketaminelevetiracetam, levetiracetammin, minphentermine, phenterminetool, tooldiphenhydramine, diphenhydramineempirical, empiricaldiff, diffmethamphetamine, methamphetaminevirtual
SOFT: The Development of a Virtual Liquid Chromatography Method Development Tool
P-75 The Development of a Virtual Liquid Chromatography Method Development Tool Melinda Uricha, Jamie Yorka, John Garrettb, Chris Nelsona, Tim Yoscaa, Justin Steimlinga a Restek, Bellefonte, PA b Analytical Innovations Inc., Dayton, OH Introduction and Background Build Laboratories implementing new…
Key words
phenazepam, phenazepammethylephedrine, methylephedrinemethaqualone, methaqualonetime, timenorketamine, norketaminelevetiracetam, levetiracetamlibrary, librarydiphenhydramine, diphenhydraminediff, diffvirtual, virtualdifferent, differentdevelopment, developmentmodeler, modelermethod, methodexisting
The Development of a Virtual Liquid Chromatography Method Development Tool (HPLC)
The Development of a Virtual Liquid Chromatography Method Development Tool a a a a b a Melinda Urich , Justin Steimling , Chris Nelson , Tim Yosca , John Garrett , Derick Lucas a b Restek Corporation, Bellefonte, Pennsylvania, USA…
Key words
acid, acidmodeler, modelerlibrary, librarymodeled, modeledgradient, gradientbuild, buildexpansions, expansionsphenazepam, phenazepamsynonym, synonymmethylephedrine, methylephedrinechromatogram, chromatogrammethaqualone, methaqualonenorketamine, norketaminelevetiracetam, levetiracetamlanguages
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike